Verition Fund Management LLC Silence Therapeutics PLC Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Verition Fund Management LLC holds 24,123 shares of SLN stock, worth $116,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,123
Previous 11,390
111.79%
Holding current value
$116,755
Previous $207,000
20.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
67Shares Held
23.6MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$14.7 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$13.7 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$11.6 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.98 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$8.05 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $174M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...